Non-compressible ABIs are associated with an increased risk of major amputation and major adverse cardiovascular events in patients with critical limb ischemia

Gagan Singh, Ehrin J. Armstrong, Stephen W. Waldo, Bejan Alvandi, Ellen Brinza, Justin Hildebrand, Ezra A Amsterdam, Misty Humphries, John R. Laird

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Ankle-brachial indices (ABIs) are important for the assessment of disease burden among patients with peripheral artery disease. Although low values have been associated with adverse clinical outcomes, the association between non-compressible ABI (ncABI) and clinical outcome has not been evaluated among patients with critical limb ischemia (CLI). The present study sought to compare the clinical characteristics, angiographic findings and clinical outcomes of those with compressible (cABI) and ncABI among patients with CLI. Consecutive patients undergoing endovascular evaluation for CLI between 2006 and 2013 were included in a single center cohort. Major adverse cardiovascular events (MACE) were then compared between the two groups. Among 284 patients with CLI, 68 (24%) had ncABIs. These patients were more likely to have coronary artery disease (p=0.003), diabetes (p<0.001), end-stage renal disease (p<0.001) and tissue loss (p=0.01) when compared to patients with cABI. Rates of infrapopliteal disease were similar between the two groups (p=0.10), though patients with ncABI had lower rates of iliac (p=0.004) or femoropopliteal stenosis (p=0.003). Infrapopliteal vessels had smaller diameters (p=0.01) with longer lesions (p=0.05) among patients with ncABIs. After 3 years of follow-up, ncABIs were associated with increased rates of mortality (HR 1.75, 95% CI: 1.12-2.78), MACE (HR 2.04, 95% CI: 1.35-3.03) and major amputation (HR 1.96, 95% CI: 1.11-3.45) when compared to patients with cABIs. In conclusion, ncABIs are associated with higher rates of mortality and adverse events among those undergoing endovascular therapy for CLI.

Original languageEnglish (US)
Pages (from-to)210-217
Number of pages8
JournalVascular Medicine (United Kingdom)
Volume22
Issue number3
DOIs
StatePublished - 2017

Fingerprint

Ankle Brachial Index
Amputation
Ischemia
Extremities
Mortality
Peripheral Arterial Disease
Chronic Kidney Failure
Coronary Artery Disease
Pathologic Constriction

Keywords

  • amputation
  • ankle-brachial index (ABI)
  • critical limb ischemia (CLI)
  • endovascular therapy
  • lower extremity
  • peripheral artery disease (PAD)
  • vascular diseases

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Non-compressible ABIs are associated with an increased risk of major amputation and major adverse cardiovascular events in patients with critical limb ischemia. / Singh, Gagan; Armstrong, Ehrin J.; Waldo, Stephen W.; Alvandi, Bejan; Brinza, Ellen; Hildebrand, Justin; Amsterdam, Ezra A; Humphries, Misty; Laird, John R.

In: Vascular Medicine (United Kingdom), Vol. 22, No. 3, 2017, p. 210-217.

Research output: Contribution to journalArticle

@article{2f6a33dc77f048438453f5019b656d53,
title = "Non-compressible ABIs are associated with an increased risk of major amputation and major adverse cardiovascular events in patients with critical limb ischemia",
abstract = "Ankle-brachial indices (ABIs) are important for the assessment of disease burden among patients with peripheral artery disease. Although low values have been associated with adverse clinical outcomes, the association between non-compressible ABI (ncABI) and clinical outcome has not been evaluated among patients with critical limb ischemia (CLI). The present study sought to compare the clinical characteristics, angiographic findings and clinical outcomes of those with compressible (cABI) and ncABI among patients with CLI. Consecutive patients undergoing endovascular evaluation for CLI between 2006 and 2013 were included in a single center cohort. Major adverse cardiovascular events (MACE) were then compared between the two groups. Among 284 patients with CLI, 68 (24{\%}) had ncABIs. These patients were more likely to have coronary artery disease (p=0.003), diabetes (p<0.001), end-stage renal disease (p<0.001) and tissue loss (p=0.01) when compared to patients with cABI. Rates of infrapopliteal disease were similar between the two groups (p=0.10), though patients with ncABI had lower rates of iliac (p=0.004) or femoropopliteal stenosis (p=0.003). Infrapopliteal vessels had smaller diameters (p=0.01) with longer lesions (p=0.05) among patients with ncABIs. After 3 years of follow-up, ncABIs were associated with increased rates of mortality (HR 1.75, 95{\%} CI: 1.12-2.78), MACE (HR 2.04, 95{\%} CI: 1.35-3.03) and major amputation (HR 1.96, 95{\%} CI: 1.11-3.45) when compared to patients with cABIs. In conclusion, ncABIs are associated with higher rates of mortality and adverse events among those undergoing endovascular therapy for CLI.",
keywords = "amputation, ankle-brachial index (ABI), critical limb ischemia (CLI), endovascular therapy, lower extremity, peripheral artery disease (PAD), vascular diseases",
author = "Gagan Singh and Armstrong, {Ehrin J.} and Waldo, {Stephen W.} and Bejan Alvandi and Ellen Brinza and Justin Hildebrand and Amsterdam, {Ezra A} and Misty Humphries and Laird, {John R.}",
year = "2017",
doi = "10.1177/1358863X16689831",
language = "English (US)",
volume = "22",
pages = "210--217",
journal = "Vascular Medicine (United Kingdom)",
issn = "1358-863X",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - Non-compressible ABIs are associated with an increased risk of major amputation and major adverse cardiovascular events in patients with critical limb ischemia

AU - Singh, Gagan

AU - Armstrong, Ehrin J.

AU - Waldo, Stephen W.

AU - Alvandi, Bejan

AU - Brinza, Ellen

AU - Hildebrand, Justin

AU - Amsterdam, Ezra A

AU - Humphries, Misty

AU - Laird, John R.

PY - 2017

Y1 - 2017

N2 - Ankle-brachial indices (ABIs) are important for the assessment of disease burden among patients with peripheral artery disease. Although low values have been associated with adverse clinical outcomes, the association between non-compressible ABI (ncABI) and clinical outcome has not been evaluated among patients with critical limb ischemia (CLI). The present study sought to compare the clinical characteristics, angiographic findings and clinical outcomes of those with compressible (cABI) and ncABI among patients with CLI. Consecutive patients undergoing endovascular evaluation for CLI between 2006 and 2013 were included in a single center cohort. Major adverse cardiovascular events (MACE) were then compared between the two groups. Among 284 patients with CLI, 68 (24%) had ncABIs. These patients were more likely to have coronary artery disease (p=0.003), diabetes (p<0.001), end-stage renal disease (p<0.001) and tissue loss (p=0.01) when compared to patients with cABI. Rates of infrapopliteal disease were similar between the two groups (p=0.10), though patients with ncABI had lower rates of iliac (p=0.004) or femoropopliteal stenosis (p=0.003). Infrapopliteal vessels had smaller diameters (p=0.01) with longer lesions (p=0.05) among patients with ncABIs. After 3 years of follow-up, ncABIs were associated with increased rates of mortality (HR 1.75, 95% CI: 1.12-2.78), MACE (HR 2.04, 95% CI: 1.35-3.03) and major amputation (HR 1.96, 95% CI: 1.11-3.45) when compared to patients with cABIs. In conclusion, ncABIs are associated with higher rates of mortality and adverse events among those undergoing endovascular therapy for CLI.

AB - Ankle-brachial indices (ABIs) are important for the assessment of disease burden among patients with peripheral artery disease. Although low values have been associated with adverse clinical outcomes, the association between non-compressible ABI (ncABI) and clinical outcome has not been evaluated among patients with critical limb ischemia (CLI). The present study sought to compare the clinical characteristics, angiographic findings and clinical outcomes of those with compressible (cABI) and ncABI among patients with CLI. Consecutive patients undergoing endovascular evaluation for CLI between 2006 and 2013 were included in a single center cohort. Major adverse cardiovascular events (MACE) were then compared between the two groups. Among 284 patients with CLI, 68 (24%) had ncABIs. These patients were more likely to have coronary artery disease (p=0.003), diabetes (p<0.001), end-stage renal disease (p<0.001) and tissue loss (p=0.01) when compared to patients with cABI. Rates of infrapopliteal disease were similar between the two groups (p=0.10), though patients with ncABI had lower rates of iliac (p=0.004) or femoropopliteal stenosis (p=0.003). Infrapopliteal vessels had smaller diameters (p=0.01) with longer lesions (p=0.05) among patients with ncABIs. After 3 years of follow-up, ncABIs were associated with increased rates of mortality (HR 1.75, 95% CI: 1.12-2.78), MACE (HR 2.04, 95% CI: 1.35-3.03) and major amputation (HR 1.96, 95% CI: 1.11-3.45) when compared to patients with cABIs. In conclusion, ncABIs are associated with higher rates of mortality and adverse events among those undergoing endovascular therapy for CLI.

KW - amputation

KW - ankle-brachial index (ABI)

KW - critical limb ischemia (CLI)

KW - endovascular therapy

KW - lower extremity

KW - peripheral artery disease (PAD)

KW - vascular diseases

UR - http://www.scopus.com/inward/record.url?scp=85019197671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019197671&partnerID=8YFLogxK

U2 - 10.1177/1358863X16689831

DO - 10.1177/1358863X16689831

M3 - Article

C2 - 28466753

AN - SCOPUS:85019197671

VL - 22

SP - 210

EP - 217

JO - Vascular Medicine (United Kingdom)

JF - Vascular Medicine (United Kingdom)

SN - 1358-863X

IS - 3

ER -